The purpose of this study was to determine whether the expression of melanoma cell adhesion molecule (MCAM/CD146), like most other endothelial adhesion molecules, is reduced in the pregnancy disorder preeclampsia, and whether it is associated with the invasiveness of trophoblast. We used immunohistochemical approaches and analyzed 42 placentas from control and pre-eclamptic patients using an anti-CD146 monoclonal antibody. Our data show that in normal placentas, CD146 staining was specifically detected in intermediate trophoblasts that are most invasive and migratory, but not detected in noninvasive cytotrophoblasts or syncytiotrophoblasts. However in pre-eclampsia, CD146 was no longer present in the intermediate trophoblasts, although it was detectable in the blood vessels. At the same time, we tested CD31/PECAM-1, another endothelial adhesion molecule, and found its negative staining for all kinds of trophoblasts in both normal and pre-eclamptic placentas. The different staining patterns of CD146 in the normal and pre-eclamptic placentas provide the first evidence that in pre-eclampsia, intermediate trophoblasts fail to express CD146, implicating that CD146 plays an important role in trophoblast invasion.
Pre-eclampsia, which often occurs in the second and the third trimesters of pregnancy, is a serious disease and is variously estimated to affect 7-10% of all pregnancies. Pre-eclampsia is typically characterized by hypertension, proteinuria and edema. In some cases, the fetus stops growing, which leads to intrauterine growth retardation. 1 Although the etiology of pre-eclampsia is unknown, numerous studies have shown that shallow trophoblast invasion into the spiral arteries and endothelial cell dysfunction are two key features in the pathogenesis of pre-eclampsia. 2, 3 During normal pregnancy, the stem cell-like cytotrophoblasts differentiate directly into syncytiotrophoblasts that synthesize and secrete a variety of pregnancy-associated hormones, and into intermediate trophoblasts that are highly invasive and migratory. 4 Intermediate trophoblasts invade the decidualized endometrium, myometrium and subsequently invade maternal spiral arteries, where the endothelial cells are replaced by the endovascular trophoblasts ( Figure 1 ). This remodeling of the uterine spiral arteries results in the diameter of the spiral arterioles increasing dramatically to form a low-resistance arteriolar system and allow an increasing blood flow to the placenta to keep pace with fetal growth. In the final stage, the endothelial lining is reconstituted. 5 In pre-eclampsia, the differentiation of cytotrophoblasts to intermediate trophoblasts is incomplete and the intermediate trophoblast invasion is shallow. Endovascular invasion does not proceed beyond the superficial portions of the uterine spiral arterioles. Thus, these spiral arterioles retain their endothelial linings and remain relatively narrow-bore, high-resistance vessels, resulting in the flow of maternal blood to the fetal-placental unit being significantly reduced relative to normal pregnancy. This poor placental perfusion is considered as an important risk factor for developing pre-eclampsia. 3 The invasive phenotype of trophoblasts is similar to that displayed by malignant tumor cells, which is highly dependent on the appropriate expression of adhesion molecules on the cell surface for anchoring and migration. 6 The failure of cytotrophoblasts to express properly many of the adhesion molecules is indicative of a deficit in cytotrophoblast differentiation and invasion. Zhou et al 7, 8 have demonstrated that pre-eclampsia is associated with the lack of cytotrophoblasts to express adhesion molecules including avb3 integrins, VE-cadherin, VCAM-1 and PECAM-1, which are normally expressed on the vascular endothelium, and the failure to mimic a vascular adhesion phenotype.
The purpose of this study was to determine whether the expression of melanoma cell adhesion molecule (MCAM/CD146), like most of the other endothelial adhesion molecules, is reduced in the placentas complicated by pre-eclampsia. The CD146, also named Mel-CAM, MUC18, 9 A32 antigen 10 and S-Endo-1, 11 is a novel member of the immunoglobulin gene superfamily and contains five extracellular Ig-like domains (V-V-C2-C2-C2), one transmembrane region and a short cytoplasmic tail.
9
CD146 is only detected in a relatively limited spectrum of normal tissues and tumors, mainly in melanoma, vascular endothelial cells, smooth muscle, implantation site intermediate trophoblast and activated T lymphocytes. [9] [10] [11] [12] [13] [14] CD146 is expressed in more than 90% of cutaneous melanomas and its expression level is associated with the invasive and metastatic potential of melanoma cells. 10, 15 Increased CD146 expression in melanoma cells promotes tumor growth and metastasis 16 and decreased CD146 expression reduces tumorigenicity.
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CD146 not only takes part in interendothelial interactions as a Ca(2 þ )-independent cell adhesion molecule, 18 but also participates in the outside-in signaling that induces phosphorylation of focal adhesion kinase (FAK) and paxillin, and a Ca(2 þ ) influx, which is closely associated with endothelial cell migration. 19, 20 Recently, we found that CD146, as an active endothelial marker, was involved in angiogenesis, which plays an important role in tumor growth and metastasis. 21 Shi and co-workers have demonstrated that CD146 is specifically and strongly expressed on human intermediate trophoblasts and trophoblastic tumors, 13 and regulates the migration of intermediate trophoblasts on smooth muscle cells. 22 However, it is unknown whether CD146 molecule is expressed in pre-eclamptic placentas in which trophoblast invasion is shallow. To answer this question, we used immunohistochemical approaches and analyzed the expression of the CD146 in the placentas from control and preeclamptic patients.
Materials and methods

Placental Sources
A total of 42 human placenta samples were obtained from Beijing Obstetrics and Gynecology Hospital, including 20 third-trimester placentas from preeclamptic patients, 16 third-trimester and 6 firstand second-trimester placentas from the women undergoing termination of apparently normal pregnancy.
Antibodies
The primary antibodies used were mouse antihuman CD146 monoclonal antibody (mAb) AA98, 21 rabbit anti-human cytokeratin (CK) polyclonal antibody (Santa Cruz Cooperation, CA, USA) and mouse anti-human CD31 antibody (Cymbus Biotechnology Ltd, Chandlers Ford, UK). Corresponding species-specific Cy3-conjugated (Sigma Chemical Co. Ltd, St Louis, MO, USA) and FITCconjugated (Jackson ImmunoResearch Labs, Inc., Baltimore, MD, USA) secondary antibodies were used. One cause of defective trophoblast invasion in pre-eclampsia Q Liu et al
Immunohistochemistry
Fresh tissues were cryosectioned (10 mm), fixed in acetone at 41C for 5 min and then preincubated with 0.3% H 2 O 2 in methanol for 30 min to quench endogenous peroxidases. The sections were blocked with 5% normal goat serum for 1 h, and incubated with the primary antibody at 41C overnight. For the negative controls, the primary antibody was omitted. The immunoreactivity was revealed using the avidin-biotin-complex peroxidase method.
Double Indirect Immunofluorescence Staining
Double indirect immunofluorescence staining was preceded as described previously. 7 Briefly, the sections were blocked with 5% normal sheep and goat serum for 30 min and then incubated with two primary antibodies, rabbit anti-cytokeratin antibody and mouse anti-CD146 antibody (or mouse anti-CD31 antibody), overnight at 41C. For negative controls, the primary antibodies were replaced by PBS. Next, the sections were incubated 60 min at 371C with two secondary antibodies, Cy3-conjugated sheep anti-mouse IgG and FITC-conjugated goat anti-rabbit IgG. After every incubation step, the sections were washed with PBS. The sections were finally examined under a microscope Olympus RX71-22-000 and photographs were taken using a cooled digital imaging camera KX14-1 under the same exposure conditions without adjusting brightness and contrast.
Quantitative Analysis
The quantitative analysis was carried out using sections of double indirect immunofluorescence staining, in which anti-cytokeratin-and anti-CD146-labeled images were captured on the same field at two different excitation wavelengths. At first, we determined the location of the intermediate trophoblasts in the anti-CD146-labeled images using the anti-cytokeratin-labeled images as a guide. We then calculated the total of the grayscale values of intermediate trophoblasts in the anti-CD146 image. Dividing the grayscale values by the total number of pixels composed of intermediate trophoblasts, the mean of the grayscale was acquired. The mean grayscale of CD146 staining was acquired, after subtracting the background of the negative sample.
Scoring was conducted independently by two observers (LQ and ZY) 'blinded' to the tissue identify. As there were no significant differences between the two sets of scores (ANOVA; P40.05 for all comparisons), the scores of one observer (LQ) were used for subsequent analysis. Scoring was conducted three times independently by LQ. As there were no significant differences among the three sets of scores (ANOVA; P40.05 for all comparisons), one set of results was used for subsequent analysis.
Results
Study Participants
The clinical details for the women who provided the third-trimester placentas for this study are summarized in Table 1 .
Immunohistochemical Localization of CD146 in Normal Placentas
To detect the expression of CD146 at the maternalfetal interface in the normal pregnancy, immunohistochemistry was performed. On the maternal side, CD146 staining was restricted in endometrial vessels (Figure 2a ), but not on glandular epithelial cells that were recognized by anti-cytokeratin ( Figure 2b) . Additionally, the decidual cells exhibited faint staining (Figure 2a) , which was further confirmed by the indirect immunofluorescence (data not shown). On the fetal side, we found that CD146 was specifically immunostained in the . Although CD31 positive staining for blood vessels (BV) was seen in the decidua (f; arrow pointed), it was not detectable in the blood vessels whose endothelium lining had been replaced by endovascular trophoblast (ET) in the second trimester (e; Â 400), whereas these endovascular trophoblasts were recognized by anti-cytokeratin (b). The scale bars stood for 100 mm.
One cause of defective trophoblast invasion in pre-eclampsia Q Liu et al blood vessels was seen in decidua (Figure 4f) , it was not detectable in the blood vessels whose endothelium lining had been replaced by endovascular trophoblast cells in the second trimester ( Figure  4e ), whereas these endovascular trophoblasts were recognized by anti-cytokeratin (Figure 4b ). The expression of CD146 and CD31 at the maternal-fetal interface in the normal pregnancy is presented in Table 2 .
Immunohistochemical Localization of CD146 in Preeclamptic Placentas
In contrast to normal placentas, the immunostaining of anti-CD146 in the pre-eclamptic placentas (n ¼ 20) was remarkably reduced or undetectable. CD146 was not only absent from the villous cytotrophoblasts and syncytiotrophoblasts ( Figure  5a and e) but also lacking from intermediate trophoblasts in trophoblastic column (Figure 5c and g), basal plate (Figure 5a and e, b and f) and maternal blood vessels (Figure 5d and h). CD146 was lacking from most intermediate trophoblasts, independent of their location in the uterus. Additionally, we observed two abnormal phenomena in the pre-eclamptic placentas. First, the trophoblastic columns were still observed in the third trimester (Figure 5c ), which normally disappear at this stage. Second, the endovascular trophoblast lining was still seen in the maternal blood vessels (Figure 5d ), which should have been re-endothelized in the normal third-trimester placentas. At the same time, we tested the CD31 expression in the pre-eclamptic placentas using anti-CD31 antibody. The staining pattern was CD31-negative for trophoblasts and positive for blood vessels (Figure 6 ), as it was in normal pregnancy.
Quantitative Analysis
We compared the immunofluorescence staining intensity of CD146 in pre-eclamptic placentas with that in normal placentas of the third trimester using grayscale analysis. As shown in Figure 7 One cause of defective trophoblast invasion in pre-eclampsia Q Liu et al of CD146 staining intensity between normal and pre-eclamptic placentas was significant (Po0.001).
Discussion
This is the first study to examine the expression of CD146 in pregnancy complicated by pre-eclampsia. From carefully selected more than 40 cases of preeclampsia and control pregnancy, we found that in the normal placentas, adhesion molecule CD146 was specifically detected on intermediate trophoblasts in both anchoring villus and decidua through all pregnant stages, whereas villous cytotrophoblast and syncytiotrophoblast were negative. However, the CD146 staining was dramatically reduced or undetectable in pre-eclampsia. From this expression pattern, implications for the role of CD146 in invasiveness can be discussed as follow.
In the control placentas, anti-CD146 antibody AA98 could differentiate intermediate trophoblasts from cytotrophoblasts and syncytiotrophoblasts, which are difficult to distinguish by conventional light microscopy. Our observations have confirmed and extended those reported by Shih et al. 13 The cytotrophoblasts are characterized as small, undifferentiated and mononucleate stem cells that display proliferative activity consistent with their germinative role. The syncytiotrophoblasts are terminally differentiated cells responsible for the synthesis of a wide variety of steroid and protein hormones. The intermediate trophoblasts, in contrast to the above two subpopulations, are larger and more polyhedral cells with most highly invasive and migratory, also referenced as invasive cytotrophoblast. 4 The specific expression of CD146 on intermediate trophoblasts can be a useful marker for distinguishing intermediate trophoblasts from the other two trophoblast populations based on both their morphologic features and immunophenotype. In addition, this finding suggests that the expression of CD146 is closely associated with the differentiation and acquired invasive phenotype of cytotrophoblasts.
Furthermore, here we provide the first evidence that the expression of CD146 is dramatically reduced or not detectable anymore on intermediate trophoblasts in pre-eclampsia. This finding supports that CD146 molecule plays significant roles in the process by which cytotrophoblasts differentiate into intermediate trophoblasts and invade the uterus and its arteries where the endothelium is replaced by endovascular trophoblasts. It has been shown that in pre-eclampsia, trophoblast invasion is abnormal and limited to the superficial deciduas. 23 The two abnormal phenomena we have observed in preeclampsia support that an aberrant trophoblast migration exists in pre-eclampsia. First, the trophoblast columns of anchoring villus were still present in the third trimester, which should disappear at this stage. Second, the endovascular trophoblast lining was still seen in the maternal blood vessels, which should be re-endothelized in normal thirdtrimester placentas. 5 The abnormal invasion in preeclampsia is often accompanied by a marked change in the expression of cell adhesion molecules on the cell surface. Zhou et al 7, 8 have reported that many endothelial adhesion molecules, such as avb3 integrin, VE-cadherin, VCAM-1 and PECAM-1, are upregulated on invasive cytotrophoblast in normal Immunofluorescence staining intensity of CD146 is analyzed in pre-eclamptic placentas and in normal placentas of the third trimester using grayscale analysis. The mean grayscale of CD146 staining in normal placentas (n ¼ 11) was 25.76673.284 (mean7s.e.), whereas that in pre-eclamptic placentas (n ¼ 20) was 3.42170.618. The difference was significant (Po0.001).
One cause of defective trophoblast invasion in pre-eclampsia Q Liu et al placentas but fail to do so in pre-eclampsia. Our data provide further evidence to support the view that pre-eclampsia is a result of abnormal cytotrophoblast differentiation that they do not display the optimum adhesion phenotype for invasion. 8 Together with the results from previous studies that CD146 is specifically expressed in melanoma cells and its expression level is closely associated with the invasive and metastatic potential of melanoma cells, 10, 15 the findings in this study strongly suggest that CD146 plays an important role in the invasiveness of both intermediate trophoblast and melanoma cell. Shih et al's 22 and our recent data indicate that CD146 is also involved in the regulation of trophoblast migration and matrix metalloproteinase secretion.
The expression of CD31/PECAM-1 in both normal and pre-eclamptic placentas has been studied by several groups. 7, 8, [24] [25] [26] [27] However, controversy still exists regarding its distribution. For instance, Zhou et al 7, 8 reported that invasive cytotrophoblasts in normal placentas expressed CD31/PECAM-1 molecule, whereas it was absent in pre-eclampsia. However, Lyall 27 showed that CD31/PECAM-1 was undetectable on any trophoblasts in both normal and pre-eclamptic placentas. Here, we tested the CD31/PECAM-1 staining compared with CD146 in normal and pre-eclamptic placentas. Our data showed that CD31/PECAM-1 exhibited negative staining on trophoblasts in both normal pregnancy and pre-eclampsia, which is in agreement with the results reported by Lyall.
In summary, this study provides a number of important insights into the contribution of cell adhesion molecules (especially endothelial CD146 and CD31) underlying normal and disordered pregnancy. First, a highly sensitive and specific CD146 expression on intermediate trophoblast provides a very useful marker for distinguishing and studying three trophoblast subpopulations. Second, the fact that pre-eclamptic trophoblasts fail to express CD146 molecule provides further evidence in understanding the role of CD146 in trophoblast invasion and the pathogenesis of pre-eclampsia. Third, the different expression patterns of CD146 and CD31 we have observed in normal pregnancy and in pre-eclampsia prompt us to further investigate the regulation and function of these molecules in the endothelium and trophoblast.
